Home
>
National Drug Code (NDC)
>
LATISSE
LATISSE - 0023-3616-05 - (bimatoprost)
Drug Information of LATISSE
| Product NDC: | 0023-3616 |
| Proprietary Name: | LATISSE |
| Non Proprietary Name: | bimatoprost |
| Active Ingredient(s): | .3 mg/mL & nbsp; bimatoprost |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | SOLUTION/ DROPS |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of LATISSE
| Product NDC: | 0023-3616 |
| Labeler Name: | Allergan, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022369 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090126 |
Package Information of LATISSE
| Package NDC: | 0023-3616-05 |
| Package Description: | 1 BOTTLE, DROPPER in 1 CARTON (0023-3616-05) > 5 mL in 1 BOTTLE, DROPPER |
NDC Information of LATISSE
| NDC Code | 0023-3616-05 |
| Proprietary Name | LATISSE |
| Package Description | 1 BOTTLE, DROPPER in 1 CARTON (0023-3616-05) > 5 mL in 1 BOTTLE, DROPPER |
| Product NDC | 0023-3616 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | bimatoprost |
| Dosage Form Name | SOLUTION/ DROPS |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 20090126 |
| Marketing Category Name | NDA |
| Labeler Name | Allergan, Inc. |
| Substance Name | BIMATOPROST |
| Strength Number | .3 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Prostaglandin Analog [EPC],Prostaglandins [Chemical/Ingredient] |
